Additionally, in Carrasco’s MM cohort from the Oncomine database, HRP2 expression was suppressed in patients with MM, with recurrence after 1 year of treatment (Supplemental Figure 1D). The gene discussed is HDGFL2; the disease is Miyoshi myopathy.